7-(MORPHOLIN-4-YL)PYRAZOLE[1,5-A]PYRIMIDINE DERIVATIVES WHICH ARE USEFUL FOR THE TREATMENT OF IMMUNE OR INFALMMATORY DISEASES OR CANCER
申请人:CELON PHARMA S.A.
公开号:US20180111939A1
公开(公告)日:2018-04-26
A compound of the general formula (I) wherein Y represents —CH
2
— or >C=0; R
1
is selected from the group consisting of A1, A2 and A3; R
2
represents dioxothiomorpholino moiety B1, piperazinyl moiety B2, azetidinyl moiety B3, or piperidinyl moiety B4; R
3
is selected from the group consisting of H, halogen, and C1-C4 alkyl; R
4
is selected from the group consisting of C1-C4 alkyl, C3-C4-cycloalkyl, C1-C4 alkyl substituted with C1-C4 alkoxy, and CHF
2
, and their pharmaceutically acceptable salts. Pharmaceutical compositions comprising said compounds and their use in the treatment of diseases of immune system, inflammatory diseases and cancer.